FDA 483 - ALK-Abello, Inc. - June 13, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
ALK-Abello, Inc. received a Form 483 following an inspection that revealed significant deficiencies in their aseptic processing operations. Key issues included inadequate validation of sterilization processes, deficient environmental monitoring, and failures in following established procedures for cleaning and contamination prevention. The observations highlight a lack of robust quality control and data integrity practices impacting the sterility assurance of their drug products.
ID · 37e6bb23-c272-4afe-9175-6eb3395c8e4d